100 related articles for article (PubMed ID: 9229289)
21. Cyclosporine-induced hypertension: evidence for maintained baroreflex circulatory control.
Lucini D; Milani RV; Ventura HO; Mehra MR; Messerli FH; Murgo JP; Regenstein F; Copley B; Malliani A; Pagani M
J Heart Lung Transplant; 1997 Jun; 16(6):615-20. PubMed ID: 9229291
[TBL] [Abstract][Full Text] [Related]
22. Fine needle aspiration biopsy in monitoring human renal transplant.
Sirpal YM
Indian J Pathol Microbiol; 1995 Oct; 38(4):393-7. PubMed ID: 9726150
[TBL] [Abstract][Full Text] [Related]
23. Early cyclosporine a withdrawal in kidney-transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions.
Goldfarb DA
J Urol; 2005 Jun; 173(6):2106-7. PubMed ID: 15879857
[No Abstract] [Full Text] [Related]
24. Quilty indicates increased risk for microvasculopathy and poor survival after heart transplantation.
Hiemann NE; Knosalla C; Wellnhofer E; Lehmkuhl HB; Hetzer R; Meyer R
J Heart Lung Transplant; 2008 Mar; 27(3):289-96. PubMed ID: 18342751
[TBL] [Abstract][Full Text] [Related]
25. Non-lymphoid cancer after liver transplantation.
Frezza EE; Fung JJ; van Thiel DH
Hepatogastroenterology; 1997; 44(16):1172-81. PubMed ID: 9261620
[TBL] [Abstract][Full Text] [Related]
26. Mitochondrial calcium deposition in association with cyclosporine therapy and myocardial magnesium depletion: a serial histologic study in heart transplant recipients.
Millane T; Wilson AJ; Patel MK; Jennison SH; Holt DW; Murday AJ; Camm AJ
J Heart Lung Transplant; 1994; 13(3):473-80. PubMed ID: 8080589
[TBL] [Abstract][Full Text] [Related]
27. Cardiac hypertrophy in liver transplant recipients: tacrolimus, cyclosporine or both?
Therapondos G; Plevris JN; Dollinger MM; Hayes PC; Flapan AD
Transplantation; 2003 Jul; 76(2):446-7; author reply 447-8. PubMed ID: 12883220
[No Abstract] [Full Text] [Related]
28. The natural history of renal function following orthotopic heart transplant.
Al Aly Z; Abbas S; Moore E; Diallo O; Hauptman PJ; Bastani B
Clin Transplant; 2005 Oct; 19(5):683-9. PubMed ID: 16146562
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
30. Stable kidney function in the second decade after kidney transplantation while on cyclosporine-based immunosuppression.
Kandaswamy R; Humar A; Casingal V; Gillingham KJ; Ibrahim H; Matas AJ
Transplantation; 2007 Mar; 83(6):722-6. PubMed ID: 17414704
[TBL] [Abstract][Full Text] [Related]
31. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.
Lerut JP; Ciccarelli O; Mauel E; Gheerardhyn R; Talpe S; Sempoux C; Laterre PF; Roggen FM; Van Leeuw V; Otte JB; Gianello P
Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040
[TBL] [Abstract][Full Text] [Related]
32. Endocardial infiltrates in human heart transplants: a serial biopsy analysis comparing four immunosuppression protocols.
Forbes RD; Rowan RA; Billingham ME
Hum Pathol; 1990 Aug; 21(8):850-5. PubMed ID: 2387576
[TBL] [Abstract][Full Text] [Related]
33. Steroid withdrawal in kidney transplant recipients: is it a safe option?
Sanfey H; Haussman G; Isaacs I; Ishitani M; Lobo P; McCullough C; Pruett T
Clin Transplant; 1997 Oct; 11(5 Pt 2):500-4. PubMed ID: 9361950
[TBL] [Abstract][Full Text] [Related]
34. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
[TBL] [Abstract][Full Text] [Related]
35. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
[TBL] [Abstract][Full Text] [Related]
36. Untreated rejection in 6-month protocol biopsies is not associated with fibrosis in serial biopsies or with loss of graft function.
Scholten EM; Rowshani AT; Cremers S; Bemelman FJ; Eikmans M; van Kan E; Mallat MJ; Florquin S; Surachno J; ten Berge IJ; Bajema IM; de Fijter JW
J Am Soc Nephrol; 2006 Sep; 17(9):2622-32. PubMed ID: 16899517
[TBL] [Abstract][Full Text] [Related]
37. Relationship between postoperative erythromycin breath test and early morbidity in liver transplant recipients.
Schmidt LE; Rasmussen A; Kirkegaard P; Dalhoff K
Transplantation; 2003 Jul; 76(2):358-63. PubMed ID: 12883193
[TBL] [Abstract][Full Text] [Related]
38. Relation of magnesium level to cyclosporine and metabolic complications in renal transplant recipients.
Ahmadi F; Naseri R; Lessan-Pezeshki M
Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):766-9. PubMed ID: 19736470
[TBL] [Abstract][Full Text] [Related]
39. The differential diagnosis between rejection and cyclosporine toxicity.
Mihatsch MJ; Ryffel B; Gudat F
Kidney Int Suppl; 1995 Dec; 52():S63-9. PubMed ID: 8587287
[No Abstract] [Full Text] [Related]
40. The interaction between clarithromycin and cyclosporine in kidney transplant recipients.
Ferrari SL; Goffin E; Mourad M; Wallemacq P; Squifflet JP; Pirson Y
Transplantation; 1994 Sep; 58(6):725-7. PubMed ID: 7940695
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
